A randomised, double-blind, placebo-controlled, dose-escalation study of multiple doses of BIIB014 administered orally in subjects with early Parkinson's disease
2007 ◽
Vol 258
(1-2)
◽
pp. 137-143
◽
Keyword(s):
2017 ◽
Vol 381
◽
pp. 231-232
◽
2011 ◽
Vol 310
(1-2)
◽
pp. 248-250
◽
Keyword(s):
2002 ◽
Vol 8
(4)
◽
pp. 271-276
◽
2016 ◽
Vol 28
◽
pp. 49-55
◽